Madan Jagasia
Faculty Member
Last active: 3/20/2014

  1. Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy. Stein RS, Wolff SN, Greer JP, Flexner JM, Goodman S, Jagasia M, Brandt SJ, Morgan DS, Arrowsmith E, McCurley TL (2001) Leuk Lymphoma 42(5): 913-22
    › Primary publication · 11697646 (PubMed)
  2. Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC. Choy H, Chakravarthy A, Devore RF, Jagasia M, Hande KR, Roberts JR, Johnson DH, Yunus F (2000) Oncology (Williston Park) 14(7 Suppl 5): 43-6
    › Primary publication · 10981290 (PubMed)
  3. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials. DeVore RF, Jagasia M, Johnson DH (1997) Semin Oncol 24(4 Suppl 12): S12-27-S12-29
    › Primary publication · 9331116 (PubMed)